FDA
approval
· 2020-04-01
FDA Approved: ARTHRITIS PAIN RELIEVER — Supplemental Application (Publix Super Markets Inc)
Summary
FDA approved a supplemental application for Publix Super Markets Inc's arthritis pain reliever containing diclofenac sodium under an ANDA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for ARTHRITIS PAIN RELIEVER (DICLOFENAC SODIUM)